Amniotics AB (OSTO:AMNI) Total Assets : kr26.09 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Total Assets?

Amniotics AB's Total Assets for the quarter that ended in Dec. 2023 was kr26.09 Mil.

During the past 12 months, Amniotics AB's average Total Assets Growth Rate was -9.80% per year. During the past 3 years, the average Total Assets Growth Rate was -30.40% per year.

During the past 5 years, Amniotics AB's highest 3-Year average Total Assets Growth Rate was 23.20%. The lowest was -30.40%. And the median was -3.60%.

Total Assets is connected with ROA %. Amniotics AB's annualized ROA % for the quarter that ended in Dec. 2023 was -93.26%. Total Assets is also linked to Revenue through Asset Turnover. Amniotics AB's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Amniotics AB Total Assets Historical Data

The historical data trend for Amniotics AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Total Assets Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

16.62

53.45

58.09

28.92

26.09

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial										36.81	28.92	26.49	23.89	26.09

Amniotics AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Amniotics AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	15.539	+	10.547
	=	26.09

Amniotics AB's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	15.539	+	10.547
	=	26.09

Amniotics AB (OSTO:AMNI) Total Assets Explanation

Total Assets is connected with ROA %.

Amniotics AB's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-23.304	/	( (23.891	+	26.086)	/ 2 )
	=	-23.304	/	24.9885
	=	-93.26 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Amniotics AB's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (23.891	+	26.086)	/ 2 )
=	0	/	24.9885
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Amniotics AB Total Assets Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.